Backed by market attractiveness analysis, total addressable market sizing, company benchmarking matrices, interactive Excel dashboards, wider supply chain intelligence, emerging startup coverage, and detailed product-level insights, The Business Research Company’s 2026 market reports are designed to offer research that is more actionable and strategically valuable than ever.
Acellular Therapy Market Poised To Hit $18.09 Billion By 2030 With A 16.9% CAGR
The acellular therapy market size has experienced rapid expansion in recent years. This market is projected to expand from $8.3 billion in 2025 to $9.69 billion in 2026, demonstrating a compound annual growth rate (CAGR) of 16.7%. Historically, this growth is a result of several factors, including heightened research activity in regenerative medicine, the early clinical acceptance of acellular matrices, rising demand for immune-safe therapies, broader applications in wound care, and advancements in biomaterial processing techniques.
The acellular therapy market is projected to experience substantial expansion in the coming years. Its value is anticipated to reach $18.09 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 16.9%. This projected increase during the forecast period is fueled by several factors, including a heightened need for customized regenerative treatments, greater capital allocation towards advanced biomaterials, an broadening range of clinical uses for acellular therapies, a concentrated effort on developing scalable regenerative solutions, and increased regulatory backing for non-cellular therapeutic approaches. Significant developments expected in this period involve a rise in the uptake of therapies based on growth factors, more frequent application of extracellular matrix scaffolds, an increasing emphasis on regenerative solutions that are cell-free, the availability of more ready-to-use regenerative products, and stronger integration of platforms for translational research.
Get A Free Sample Report With In-Depth Market Insights:
Acellular Therapy Market Growth Backed By Core Demand Fundamentals
The increasing integration of regenerative medicine is anticipated to drive the growth of the acellular therapy market. Regenerative medicine encompasses medical approaches aimed at repairing, replacing, or regenerating human cells, tissues, or organs through biological processes and therapies to restore their normal function. The embrace of regenerative medicine is on the rise as biotechnology research activity expands globally, leading to an increased number of developers, more robust pipelines, and wider therapeutic explorations. Acellular therapy (AT) supports this trend by providing bioactive, cell-free therapeutic materials, including extracellular vesicles, secretomes, and other biologically active components, which enhance regenerative strategies with improved safety and standardized dosing. For instance, in june 2024, data from the Centre for Commercialization of Regenerative Medicine (CCRM), a Canada-based regenerative medicine organization, indicated that there were 2,848 cell and gene therapy developers worldwide as of april 2024, marking an 11% increase from quarter four (Q4) 2023. Furthermore, 1,751 active regenerative medicine clinical trials were underway globally as of april 2024, highlighting sustained clinical engagement and a surge in regenerative research. Therefore, the expanding adoption of regenerative medicine is propelling the growth of the acellular therapy market.
Acellular Therapy Market Segmentation: How Does The Market Break Down By Category?
The acellular therapy market covered in this report is segmented –
1) By Type: Acellular Dermal Matrices; Acellular Amniotic Membranes; Acellular Umbilical Cord Products; Other Types
2) By Disease: Parkinson’s; Alzheimer’s; Chronic Wounds; Sclerosis; Cancer
3) By Scaffold: Fused Deposition Modeling (FDM); Cell Laden Hydrogel; Extracellular Matrix (ECM); Selective Laser Sintering (SLS)
4) By Application: Hepatology; Orthopedic; Cardiology; Neurology; Oncology; Gastroenterology
5) By End-User: Hospitals; Clinics; Ambulatory Surgical Centers; Research Institutes
Subsegments:
1) By Acellular Dermal Matrices: Human Derived Dermal Matrices; Animal Derived Dermal Matrices; Cross Linked Dermal Matrices; Non Cross Linked Dermal Matrices
2) By Acellular Amniotic Membranes: Cryopreserved Amniotic Membranes; Dehydrated Amniotic Membranes; Lyophilized Amniotic Membranes; Laminated Amniotic Membranes
3) By Acellular Umbilical Cord Products: Wharton Jelly Based Products; Umbilical Cord Patch Products; Umbilical Cord Powder Products; Umbilical Cord Sheet Products
4) By Other Types: Acellular Cartilage Matrices; Acellular Bone Matrices; Acellular Vascular Grafts; Acellular Tendon And Ligament Scaffolds
Acellular Therapy Market Growth Trends Reshaping The Competitive Landscape
Companies active within the acellular therapy market are primarily focused on developing small extracellular vesicle (sEV) therapies to support tissue regeneration, diminish inflammation, and modify immune responses by directly delivering bioactive vesicles to affected tissues, without incorporating living cells. Small extracellular vesicle (sEV) therapies are categorized as acellular products derived from cultured cells, which carry proteins, ribonucleic acids (RNAs), and signaling molecules, thereby enabling precise regulation of cellular activity, repair of injured tissue, and immunomodulation. For example, in march 2025, evast bio, a US-based biotechnology firm, unveiled a small extracellular vesicle (sEV) therapy for knee osteoarthritis, designed to address crucial challenges in inflammatory joint disease. This therapy delivers exosomes to inflamed cartilage, promoting the regeneration of cartilage extracellular matrix, reducing inflammatory markers, and improving joint function, marking it as a pioneering acellular therapy (AT) for musculoskeletal inflammation and a model for future extracellular vesicle (sEV) based treatments.
Acellular Therapy Market Competitive Overview And Top Companies
Major companies operating in the acellular therapy market are Thermo Fisher Scientific, FUJIFILM Holdings Corp., Lonza Group AG, Smith+Nephew, Charles River Laboratories, Sartorius AG, Integra LifeSciences, AGC Biologics, Organogenesis Holdings Inc., MiMedx Group Inc., Vericel Corporation, Avita Medical, Capricor Therapeutics, RoosterBio Inc., Creative Biolabs, Evox Therapeutics Ltd., ILIAS Biologics, Aruna Biomedical, Stem Cell Medicine Ltd., Aegle Therapeutics Corp, Direct Biologics LLC., BioCardia Inc., BioRestorative Therapies Inc., and EverZom.
View The Full Acellular Therapy Market Report:
Acellular Therapy Market Top Region: Where Does Most Revenue Come From?
North America was the largest region in the acellular therapy market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the acellular therapy market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Reach Out To Our Team:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas: +1 310-496-7795
Asia: +44 7882 955267 & +91 8897263534
Europe: +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
